China Biotechnology Services (08037.HK) presented the initial follow-up results of boron neutron capture therapy at the 22nd Annual Academic Conference of the Japanese Society for Neutron Capture Therapy.

Zhitong Finance APP News: China Biotechnology Services (08037.HK) announced that at the 22nd Annual Conference of the Japanese Society for Neutron Capture Therapy (JSNCT22) held at Kyoto University in Japan, its subsidiary, Peng Bo (Hainan) Boron Neutron Medical Technology Co., Ltd., presented a verbal report on the first ten cases of head and neck cancer patients treated with Boron Neutron Capture Therapy (BNCT) at Peng Bo (Hainan) Hospital. The report included clinical real-world data following treatment after three months (90 days).